Andreas Karachristos
About
In The Last Decade
Andreas Karachristos
29 papers receiving 525 citations
Peers
Comparison fields: 5 of 56
- Surgery 378
- Oncology 255
- Pulmonary and Respiratory Medicine 203
- Hepatology 82
- Epidemiology 80
Countries citing papers authored by Andreas Karachristos
This map shows the geographic impact of Andreas Karachristos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Karachristos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Karachristos more than expected).
Fields of papers citing papers by Andreas Karachristos
This network shows the impact of papers produced by Andreas Karachristos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Karachristos. The network helps show where Andreas Karachristos may publish in the future.
Co-authorship network of co-authors of Andreas Karachristos
This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Karachristos. A scholar is included among the top collaborators of Andreas Karachristos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Karachristos. Andreas Karachristos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 17 | |
| 4 | 0 | |
| 5 | 11 | |
| 6 | 7 | |
| 7 | 14 | |
| 8 | 5 | |
| 9 | 0 | |
| 10 | 2 | |
| 11 | 7 | |
| 12 | 8 | |
| 13 | 17 | |
| 14 | Targeting alloantibody production with bortezomib: does it make more sense? | 1 |
| 15 | 2 | |
| 16 | 11 | |
| 17 | 31 | |
| 18 | 12 | |
| 19 | 24 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.